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Summary
We recently described an autosomal dominant inclusion-
body myopathy characterized by congenital joint con-
tractures, external ophthalmoplegia, and predominantly
proximal muscle weakness. A whole-genome scan, per-
formed with 161 polymorphic markers and with DNA
from 40 members of one family, indicated strong linkage
for markers on chromosome 17p. After analyses with
additional markers in the region and with DNA from
eight additional family members, a maximum LOD
score (Zmax) was detected for marker D17S1303
( ; recombination fraction ). Haplo-Z  7.38 (v)  0max
type analyses showed that the locus (Genome Database
locus name: IBM3) is flanked distally by marker
D17S945 and proximally by marker D17S969. The po-
sitions of cytogenetically localized flanking markers sug-
gest that the location of the IBM3 gene is in chromosome
region 17p13.1. Radiation hybrid mapping showed that
IBM3 is located in a 2-Mb chromosomal region and that
the myosin heavy-chain (MHC) gene cluster, consisting
of at least six genes, co-localizes to the same region. This
localization raises the possibility that one of the MHC
genes clustered in this region may be involved in this
disorder.
Introduction
Familial or hereditary inclusion-bodymyopathy (HIBM)
constitutes a heterogeneous group of disorders histolog-
ically characterized by muscle fibers with rimmed vac-
uoles and inclusions consisting of filaments with a di-
ameter of 15–21 nm (Griggs et al. 1995; Askanas and
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Engel 1998a). Autosomal recessive inheritance of HIBM
(MIM 600737) has been described in quadriceps-sparing
HIBM, with onset in early adulthood (Argov and Yarom
1984). This disorder has been linked to chromosome
9p1–q1 (Mitrani Rosenbaum et al. 1996; Argov et al.
1997). Autosomal dominant inheritance of HIBM has
also been described (MIM 147420), but no chromoso-
mal linkage has been presented to date. No unique clin-
ical features, such as congenital joint contractures or
ophthalmoplegia, were found in these patients, although
the muscle weakness seemed to be predominantly prox-
imal with a limb-girdle distribution (McKee et al. 1992;
Neville et al. 1992; Sivakumar and Dalakas 1996). Sim-
ilar histopathological changes have been reported in
other hereditary myopathies, such as oculopharyngeal
muscular dystrophy (Coquet et al. 1990), oculophar-
yngeal muscular dystrophy with distal myopathy (Fu-
kuhara et al. 1982), Welander distal myopathy (Lind-
berg et al. 1991), tibial muscular dystrophy (Udd et al.
1993), and distal myopathy with rimmed vacuoles
(DMRV; Nonaka et al. 1981). DMRV has recently been
linked to chromosome 9 and is possibly allelic to quad-
riceps-sparing HIBM (Ikeuchi et al. 1997).
We recently described an autosomal dominant HIBM
in a large Swedish family with 19 affected persons (Darin
et al. 1998). Characteristic clinical features were con-
genital joint contractures that normalized during early
childhood, external ophthalmoplegia, and predomi-
nantly proximal muscle weakness and atrophy. To iden-
tify a gene locus (HGM locus IBM3) for this disease,
we performed linkage analysis by means of polymorphic
DNA markers from 40 family members. A genomewide
analysis showed linkage to chromosome 17p markers.
Subjects and Methods
Families
Data from the large multigeneration family (fig. 1)
from western Sweden described elsewhere (Darin et al.
1998) were analyzed for myopathy inherited as an au-
tosomal dominant trait. This familial disorder and the
criteria for the diagnosis of myopathy have recently been
reported (Darin et al. 1998). Characteristic clinical fea-
Figure 1 Pedigree of the investigated family and haplotype/recombination analysis of the analyzed family data. The data indicate the most likely paternal and maternal haplotypes for the region
D17S1353–D17S921 and a distal and a proximal border for the IBM3 locus. Affected individuals are indicated by blackened symbols, unaffected individuals by unblackened symbols. The haplotype
segregating with IBM3 is boxed; uninformative loci are indicated by a question mark (?). Individuals III:7 and IV:10 display recombination events, giving a distal border for the IBM3 locus, whereas
recombinations for individuals III:9, III:21, and IV:16 indicate a proximal border. In summary, the haplotype/recombination data indicate that the IBM3 locus is located in the region defined distally
by marker D17S974 and proximally by D17S969. The pedigree has been somewhat distorted and truncated to avoid identification.
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tures were congenital joint contractures that normalized
during early childhood, external ophthalmoplegia, and
predominantly proximal muscle weakness and atrophy.
Hand tremor was frequently associated. The clinical
course was nonprogressive in childhood, although most
adult patients experienced deterioration of muscle func-
tion starting at ∼40 years of age. Focal disorganization
of myofilaments occurred in childhood, whereas adults
with progressive muscle weakness showed dystrophic
changes and rimmed vacuoles with cytoplasmic and in-
tranuclear inclusions of 15–21-nm filaments. Occasional
congophilic inclusions, accumulations of ubiquitin, and
inclusions that showed immunoreactivity with an anti-
body to hyperphosphorylated tau (SMI-31) were addi-
tional features suggesting that this myopathy should be
grouped with the HIBMs.
The family members were diagnosed as affected or
unaffected by one of us (N.D.), who applied a stan-
dardized questionnaire and a clinical examination form.
Informed consent was given by each individual. Forty-
eight family members were examined. The probands
were classified as definitely affected if they had symp-
toms and clinical signs of myopathy in addition to ex-
ternal ophthalmoplegia. They were considered unaf-
fected if they were without definite symptoms and had
normal muscle findings. Muscle biopsy findings were not
used as inclusion criteria. Those cases in which family
members did not fulfill these criteria were considered
“unclear.” Obstetric, pediatric, child health clinic, and
other relevant medical files were reviewed. A follow-up
interview and clinical examination were performed 4
years after the first examination. In the initial total-ge-
nome scan, data from 40 family members were used.
After linkage to chromosome 17 markers had been de-
tected, data from an additional set of eight family mem-
bers were analyzed for markers in this region only.
DNA Isolation, Genotyping, and Linkage Analysis
DNA was isolated from venous blood samples anti-
coagulated with EDTA and extracted according to stan-
dard procedures. PCR was performed according to stan-
dard procedures. In brief, amplifications were done in a
20-ml volume containing 125 ng of genomic DNA; 15
pmol of each primer; 10 mM Tris HCl (pH 8.3); 50 mM
KCl; 1.5 mM MgCl2; 0.001% (w/v) gelatin; 4.4 nmol
of each dATP, dCTP, dGTP, dTTP; 0.66 mCi a[32P]-
dCTP; and 0.55 U TaqDNA polymerase (Perkin-Elmer).
Amplifications were done in a Hybaid Omnigene Tem-
perature Cycler. Simple-sequence-repeat polymorphisms
(SSRPs) were determined by the length of amplified PCR
products on a 6% polyacrylamide/7 M urea sequencing
gel. After drying, the gel was exposed to a Fuji X-ray
film overnight at room temperature.
Two-point linkage analyses were performed with the
MLINK and the ILINK programs from the LINKAGE
5.1 package (Lathrop et al. 1984). The model used for
analyses was an autosomal dominant inheritance with
full penetrance (1.0) and a disease allele frequency of
.0001.
A screen of the genome was done by means of primer
pairs set denoted “CHLC [Cooperative Human Linkage
Center] Human Screening Set/Weber version 6a,” which
consists of 161 markers spaced over the genome (Co-
operative Human Linkage Center). The primers were
synthesized through the Nordic Genetic Marker Repos-
itory (C. Wadelius, personal communication). After the
initial gene localization, additional markers from the
chromosome 17p gene region were used. These were
from the Ge´ne´thon (Dib et al. 1996) and the Cooperative
Human Linkage Center (Murray et al. 1994) linkage
maps. The recently published integrated maps (Broman
et al. 1998; Marshfield Medical Research Foundation)
were used for estimation of distances between markers
of different groups.
Estimation of Distances between DNA Markers with a
Radiation Hybrid Panel
Relevant markers in the chromosome 17 region
(D17S969, D17S1303, D17S974, and D17S945), to-
gether with sequence-tagged sites (STSs) for two can-
didate genes, were tested versus the Stanford Human
Genome Center G3 radiation hybrid mapping panels
(Research Genetics). The two STSs for genes tested were
PMP22 exon 3 (primers: PMPex3F: 5′-CCA TGG CCA
GCT CTC CTA AC-3′ and PMPex3R 5′-CAT TCCGCA
GAC TTT GAT GC-3′; 59C) and myosin, heavy poly-
peptide 2, skeletal muscle, adult (Genome Database lo-
cus: MYH2; primers: LL120: 5′-TCA AGC TTC TTC
CTC CTC CTC AGC TCT TTC AG-3′ and LL77: 5′-
TTA AGC CCC TCC TCA AGA GTG CA-3′; 60C).
The STS primers for the MYH2 and the PMP22 genes
were derived from the Genome Database. Data were
analyzed by means of both the RH-map software pack-
age (Boehnke et al. 1991) and electronic submission to
the RH-server (Stanford Human Genome Center).
Markers were mapped versus the 1000:1 bins map from




Data from 40 individuals in the family were used in
the analyses (for pedigree, see fig. 1). Linkage analyses
were performed by means of microsatellite polymor-
phisms from the Cooperative Human Linkage Center
Human Screening Set/Weber version 6a, which contain
161 markers spaced over the genome. The data were
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Figure 2 Summary of radiation hybrid data from the IBM3 gene
region on 17p13.1. The MYH2 gene was found to localize in close
proximity to markers D17S974 and D17S1303 in the IBM3 gene
region, whereas the control gene PMP22, although localized to 17p,
clearly mapped outside the IBM3 critical region. Genetic distances are
derived from Broman et al. (1998) and the RH-bin information is
derived from RH-server (Stanford Human Genome Center).
Table 1
Two-Point LOD Score Values for Linkage between IMB3 and Chromosome 17
Markers
MARKER
LOD SCORE AT v 
Zmax vAT Zmax0 .01 .05 .1 .2 .3 .4
D17S1353  -1.02 .78 1.30 1.39 1.02 .46 1.39 .2
D17S945  3.95 4.85 4.80 4.01 2.83 1.39 4.85 .05
D17S974 2.05 2.01 1.83 1.61 1.14 .67 .27 2.05 0
D17S1303 7.38 7.25 6.74 6.07 4.66 3.12 1.48 7.38 0
D17S954 2.37 2.33 2.15 1.93 1.46 .97 .47 2.37 0
D17S1875 4.76 4.68 4.35 3.92 3.00 1.99 .90 4.76 0
D17S969  3.95 4.85 4.80 4.01 2.83 1.40 4.85 .05
D17S799  -.12 1.63 2.08 2.01 1.47 .71 2.08 .1
D17S921  -2.46 .01 .79 1.09 .82 .36 1.09 .2
analyzed by means of the MLINK and ILINK programs
(data available on request) in the LINKAGE 5.1 pack-
age. One region in chromosome region 17p gave a strong
indication of linkage. Additional markers in this region
were subsequently analyzed with DNA from eight ad-
ditional family members. We found a region ranging
from marker D17S1353 to marker D17S921 that was
strongly linked to the IBM3 locus. Pairwise LOD scores
for these markers are shown in table 1. Four markers
(D17S974, D17S1303, D17S954, and D17S1875) had
a combined LOD score that was maximal (Zmax) at a
recombination fraction (v) of zero (v at ). ForZ  .00max
four markers in the region, the maximal LOD score was
14, with a peak at D17S1303 ( at .)Z  7.38 v  .00max
Recombination Analysis
To further narrow the region of the IBM3 gene locus,
we performed a family haplotype analysis for the region
D17S1353 to D17S921 (fig. 1). Several recombination
events were detected between markers D17S945 and
D17S974—for example, from individuals II:1 to III:7
and from individuals III:11 to IV:10. These findings place
D17S945 distal to the IBM3 locus. Furthermore, recom-
bination events were detected between markers
D17S1875 and D17S969—for example, from individ-
uals II:1 to III:9 and from individuals II:9 to III:21. These
findings place D17S969 proximal to the IBM3 locus.
Taken together, the findings from the family recombi-
nation analyses indicate that the IBM3 gene is located
in a region defined distally by marker D17S945 and
proximally by marker D17S969 (fig. 2). On a recently
published integrated map, this region is estimated at ∼6
cM (Broman et al. 1998).
Radiation Hybrid Data for 17p
Four polymorphic markers (D17S969, D17S1303,
D17S974, and D17S945) in the IBM3 gene region were
analyzed by means of the StanfordHumanGenomeCen-
ter G3 radiation hybrid mapping panel. In addition, STS
markers for one of the myosin heavy-chain (MHC) gene
family members, MYH2, and for the PMP22 gene (in-
volved in Charcot-Marie-Tooth disease, used as a con-
trol) were included in the analysis. The PCR patterns of
the four polymorphic markers used were found to be
very similar (data not shown). The most-likely deviant
clones, markers D17S969 and D17S945, had a calcu-
lated distance of ∼2 Mb (separated by ∼80–100 cR),
whereas markers D17S1303 and D17S974 were found
to map between these markers. This is also corroborated
by the Stanford Human Genome Center RH-map, ver-
sion 2.0, where the markers D17S945, D17S974,
D17S1303, and D17S969 were found to map to the
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1000:1 bins 14, 15, 15, and 16, respectively, of the 87
bins on chromosome 17. The MYH2 gene had a pattern
of positive clones most similar to markers D17S1303
and D17S974. MYH2 could be shown to link strongly
(LOD score  9.87) to markers in bin 15, whereas
PMP22 had a pattern very different from the other five
markers and linked strongly (LOD score 12.38) tomark-
ers in bin 19 (fig. 2).
Discussion
We have shown, by means of linkage analysis, that
the IBM3 gene is linked to polymorphic DNA markers
on chromosome 17p. By means of recombination/hap-
lotype analysis, the gene could be mapped to the region
between markers D17S969 on the proximal side and
D17S945 on the distal side in 17p13.1. This region is
∼6 cM, on a recently published integrated map. To fur-
ther characterize the region on the physical map, four
microsatellite markers were tested versus the Stanford
Human Genome Center G3 radiation hybrid map, to-
gether with one of the MHC genes known to cluster
to the region. The most likely order of the polymor-
phic markers in the radiation hybrid analysis
is 17pter–D17S945–D17S974–D17S1303–D17S969–
17cen (fig. 2). Two interesting features of the analysis
were that (1) MYH2 clearly mapped close to the central
markers D17S974 and D17S1303 and thus locates
within the IBM3 critical region, and (2) the distance
between the markers flanking the IBM3 gene region,
such as D17S945 and D17S969, is most likely ∼2 Mb
and thus smaller than the distance indicated by the ge-
netic map, which is ∼6 cM. A group of five to six MHC
genes are known to cluster to the 17p13.1 gene region
(Leinwand et al. 1983; Yoon et al. 1992; Soussi Yani-
costas et al. 1993). Considering the nature of the dis-
order, these genes are likely candidates for being the
IBM3 locus.
Myosin consists of two MHC and two pairs of non-
identical myosin light chains. The human MHC genes
in striated muscle are organized in two chromosomal
clusters. The alpha and slow/beta cardiac MHC genes
are located on chromosome 14q (Saez et al. 1987). The
other five to six MHC skeletal muscle genes, including
embryonic, perinatal, the adult fast gene (2A, 2X, and
probably 2B), and an unidentified gene that probably
corresponds to the MHC-extraocular, are clustered on
a 300–600-kb segment on chromosome 17p13.1 (Lein-
wand et al. 1983; Yoon et al. 1992; Soussi Yanicostas
et al. 1993).
Mutations in MHC genes have only rarely been as-
sociated with disease. Mutations in the beta cardiac my-
osin (MYH7) gene on chromosome 14q have been
shown to cause familial hypertrophic cardiomyopathy
(FHC; Towbin 1998), a disorder that may present with
an associated central-core pathology in skeletal muscle
(Fananapazir et al. 1993). Mutations in several other
genes that encode sarcomere-associated proteins have
recently been identified as causes of FHC (Towbin 1998),
and mutations of cardiac actin have been associatedwith
dilated cardiomyopathy (Olson et al. 1998). Alpha tro-
pomyosin slow (TPM3) mutations are associated with
rare cases of autosomal dominant and recessive nemaline
myopathy (Laing et al. 1995), and myosin light chain
mutations are associated with a rare myopathy in human
heart and skeletal muscle (Poetter et al. 1996).
A mutation in one of the MHC genes may be re-
sponsible for the morphological and clinical findings pre-
sented here. In addition to autosomal dominant car-
diomyopathy, the MYH7 gene also causes various
degrees of myopathic changes in skeletal muscle with
central cores (Fananapazir et al. 1993). This is similar
to the focal disorganization of myofilaments with mini-
cores found in the disorder described elsewhere (Darin
et al. 1998). Because the MHC genes are expressed in
different fiber types and at different times during de-
velopment (Whalen et al. 1981; Wieczorek et al. 1985),
a mutation in an MHC gene might be responsible for
the characteristic external ophthalmoplegia and the pe-
culiar course of our disorder with congenital joint con-
tractures that normalize during early childhood and then
deteriorate in middle adulthood.
The relation of myosin with rimmed vacuoles is not
clear. Rimmed vacuoles are considered to be autophagic
in nature (Fukuhara et al. 1980). In DMRV, it has been
hypothesized that myosin and other sarcomere-associ-
ated proteins, after a partial degradation by extralyso-
somal processes, stimulate lysosome formation and in-
duce autophagic rimmed vacuoles (Kumamoto et al.
1982). Rimmed vacuoles and filamentous inclusions
have also been described in tibial muscular dystrophy
(Udd et al. 1993), in which another sarcomere-associ-
ated protein, titin, is a possible candidate gene (Hara-
vuori et al. 1998). Further identification of the gene and
gene product responsible for the phenotype in this family
will be important for understanding the molecular back-
ground and the pathogenesis of HIBM. Such will also
permit studies on the relationship between these disor-
ders and clinically and morphologically related diseases
such as certain hereditary congenital and distal
myopathies.
The characteristic filamentous inclusions, congophilic
inclusions, and several of the pathologically accumulat-
ing proteins that have been described in HIBM were
originally described in a sporadic inflammatory myopa-
thy named inclusion-body myositis (IBM), which has
been considered the most common muscle disease that
begins at 150 years of age (Askanas and Engel 1998b).
The identification of genes associated with HIBM may,
therefore, give new insights into the pathogenesis of the
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progressive and debilitating sporadic IBM. The large
sizes of the MHC genes located on 17p13.1 and the fact
that information is incomplete on the gene structure for
most of them are factors that will make the identification
of the mutation difficult. Nevertheless, analyses for mu-
tations in the MYH genes in the family presented here
are in progress.
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